Benign and Low Grade Serous Epithelial Tumors: Recent Developments and Diagnostic Problems.

Area of Science:

• Gynecologic Pathology
• Ovarian Neoplasms
• Serous Carcinogenesis

Background:

• Low-grade ovarian serous neoplasia (S-LMP) encompasses tumors with a generally favorable prognosis, but recurrence and progression to carcinoma are documented.
• Significant advancements in understanding serous borderline and malignant pelvic epithelial neoplasms have occurred in the last decade.
• Controversy persists regarding the classification and management of S-LMP.

Purpose of the Study:

• To review recent advances in low-grade ovarian serous neoplasia.
• To emphasize key diagnostic criteria, differential diagnosis, and disease classification.
• To explore the proposed S-LMP - low-grade serous carcinoma pathway.

Main Methods:

• Review of current literature on low-grade ovarian serous neoplasia.
• Analysis of diagnostic criteria and risk factors for disease progression.
• Examination of proposed molecular pathways in serous carcinogenesis.

Main Results:

• Extraovarian implant status is the primary predictor of progressive disease in S-LMP.
• Progression typically leads to low-grade serous carcinoma, rarely high-grade carcinoma.
• A proposed S-LMP - low-grade serous carcinoma pathway is supported by gene expression profiling and shared mutations (KRAS/BRAF).

Conclusions:

• Low-grade serous carcinoma demonstrates poor response to conventional platinum-based chemotherapy.
• Tailored therapies for S-LMP with invasive implants and low-grade serous carcinoma are under active investigation.
• Risk stratification models are essential for guiding future treatment strategies.